Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
Department of Radiology and Nuclear Medicine, University Medical Centers Amsterdam, Free University of Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Eur J Nucl Med Mol Imaging. 2023 Jul;50(8):2258-2270. doi: 10.1007/s00259-023-06194-4. Epub 2023 Mar 22.
Monoclonal antibody (mAb)-based PET (immunoPET) imaging can characterise tumour lesions non-invasively. It may be a valuable tool to determine which patients may benefit from treatment with a specific monoclonal antibody (mAb) and evaluate treatment response. For Zr immunoPET imaging, higher sensitivity of state-of-the art PET/CT systems equipped with silicon photomultiplier (SiPM)-based detector elements may be beneficial as the low positron abundance of Zr causes a low signal-to-noise level. Moreover, the long physical half-life limits the amount of activity that can be administered to the patients leading to poor image quality even when using long scan durations. Here, we investigated the difference in semiquantitative performance between the PMT-based Biograph mCT, our clinical reference system, and the SiPM-based Biograph Vision PET/CT in Zr immunoPET imaging. Furthermore, the effects of scan duration reduction using the Vision on semiquantitative imaging parameters and its influence on image quality assessment were evaluated.
Data were acquired on day 4 post 37 MBq Zr-labelled mAb injection. Five patients underwent a double scan protocol on both systems. Ten patients were scanned only on the Vision. For PET image reconstruction, three protocols were used, i.e. one camera-dependent protocol and European Association of Nuclear Medicine Research Limited (EARL) standards 1 and 2 compliant protocols. Vision data were acquired in listmode and were reprocessed to obtain images at shorter scan durations. Semiquantitative PET image parameters were derived from tumour lesions and healthy tissues to assess differences between systems and scan durations. Differently reconstructed images obtained using the Vision were visually scored regarding image quality by two nuclear medicine physicians.
When images were reconstructed using 100% acquisition time on both systems following EARL standard 1 compliant reconstruction protocols, results regarding semiquantification were comparable. For Vision data, reconstructed images that conform to EARL1 standards still resulted in comparable semiquantification at shorter scan durations (75% and 50%) regarding 100% acquisition time.
Scan duration of Zr immunoPET imaging using the Vision can be decreased up to 50% compared with using the mCT while maintaining image quality using the EARL1 compliant reconstruction protocol.
基于单克隆抗体(mAb)的正电子发射断层扫描(immunoPET)成像可以无创性地对肿瘤病变进行特征描述。它可能是一种有价值的工具,可以确定哪些患者可能受益于特定单克隆抗体(mAb)的治疗,并评估治疗反应。对于 Zr 免疫 PET 成像,配备基于硅光电倍增管(SiPM)的探测器元件的最先进的 PET/CT 系统的更高灵敏度可能是有益的,因为 Zr 的低正电子丰度导致低信噪比。此外,较长的物理半衰期限制了可以给予患者的活动量,导致即使使用较长的扫描时间,图像质量也很差。在这里,我们研究了基于 PMT 的 Biograph mCT(我们的临床参考系统)和基于 SiPM 的 Biograph Vision PET/CT 在 Zr 免疫 PET 成像中的半定量性能差异。此外,还评估了使用 Vision 减少扫描时间对半定量成像参数的影响及其对图像质量评估的影响。
在注射 37 MBq Zr 标记的 mAb 后第 4 天采集数据。五名患者在两种系统上进行了双扫描方案。十名患者仅在 Vision 上进行扫描。对于 PET 图像重建,使用了三种方案,即一种依赖于相机的方案和符合欧洲核医学研究协会(EARL)标准 1 和 2 的方案。Vision 数据以列表模式采集,并进行后处理以获得较短扫描时间的图像。从肿瘤病变和健康组织中得出半定量 PET 图像参数,以评估系统和扫描时间之间的差异。两名核医学医生对使用 Vision 获得的不同重建图像进行了视觉评分,以评估图像质量。
当使用符合 EARL 标准 1 的协议对两种系统进行 100%采集时间的图像重建时,结果在半定量方面具有可比性。对于 Vision 数据,在使用符合 EARL1 标准的重建方案时,在较短的扫描时间(75%和 50%)下仍可获得可比的半定量结果。
与使用 mCT 相比,使用 Vision 进行 Zr 免疫 PET 成像的扫描时间可以减少 50%,同时使用符合 EARL1 标准的重建协议保持图像质量。